2023年4月21日

好處還開發了一個突破雞細胞株用於懸浮細胞培養。好處的食物,一個培養肉類、禽類和海鮮公司,宣布一係列新的消費產品由真正的動物細胞。正等待監管部門的審查,這些栽培碎肉產品擴大上行的商業投資組合將包括一係列的選項,比如雞肉香腸、雞肉三明治和餃子。此外,上行宣布開發出一種突破雞細胞株用於懸浮細胞培養,可以大大減少這些碎肉產品的生產成本。好處的食物一直致力於發展不同範圍的產品,自2015年成立以來,為消費者提供的最終目標肉在一個新的和更好的方式。這包括whole-textured產品的發展,如雞片、碎肉產品簡單的紋理,可以迅速擴大,以更低的成本。公司最初將啟動小規模種植雞裏脊,緊隨其後的是下一代的產品。上行也實現了關鍵突破的碎肉產品組合,包括開發一個雞細胞係,不需要血小板源生長因子(PDGF),一個最昂貴的原料用於支持細胞生長。自2016年推出世界上第一個種植牛肉丸,公司一直致力於改進生產方法為其產品。宣布在2021年12月,上行的發展一個動物部分流單元格提要對於它的一些產品,進一步展示其奉獻肉類生產的可持續發展和人性化。 "For us to realize the impact that we want to have, we've always known that we need to provide a portfolio that matches the diversity of formats and forms that consumers expect," said Dr. Uma Valeti, CEO and founder of Upside Foods. "Our first consumer product, a cultivated chicken filet, demonstrates our ability to deliver the experience of eating a more complex and textured meat product. On the other hand, our ground products are extremely versatile and enable us to explore a range of exciting formats and flavor experiences, while also allowing us to scale faster and make cultivated meat more accessible. Both are exquisite and equally delicious, and we can't wait for people to try them." "Our breakthrough in developing a PDGF-independent cell line represents a major scientific achievement in the production of cultivated meat," said Kevin Kayser, SVP of research and development at Upside Foods. "By eliminating the most expensive growth factor in our process, we're able to dramatically reduce cost and increase scale. We look forward to leveraging the insights gained to drive future innovations and continue to work towards making all of our products more delicious, affordable, humane, and sustainable." Upside's ground meat products will be made up of real animal cells, along with other ingredients like herbs, vegetables, spices and plant-based proteins. The regulatory process for Upside's ground products, which are based on cells grown in a suspension culture, will be separate from that of its first product, an adherent tissue-based process for which the company received a landmark first-in-the-world "green light" from the U.S. Food and Drug Administration (FDA) last year. That product is currently undergoing review by the U.S. Department of Agriculture (USDA) for remaining approvals. Meanwhile, Upside will continue working with both the FDA and USDA to bring its next generation of products to market. Source: Upside Foods